Rology secures major funding to scale its AI-driven radiology platform across MENA, boosting diagnostic speed, cutting costs, and expanding access for hospitals.
Rology has secured a significant new growth round, backed by some of the biggest names in global healthcare, a move that’s already stirring excitement across the MENA healthtech ecosystem. The round brought in The Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit Impact Fund, and MIT Solve Innovation Future, underscoring strong confidence in what the Cairo-born startup is building: faster, more accessible, AI-powered radiology for hospitals that are often overstretched.
Also Read: WTDcare Clinches Pre-Seed Funding to Revolutionize Saudi Healthtech
Rology’s CEO, Amr Abodraiaa, described the funding as a strategic alignment with “mission-aligned leaders” committed to improving diagnostic access. And truth be told, the backing makes sense given the company’s trajectory. Rology has evolved into a crucial infrastructure layer for hospitals across more than a dozen countries, from major health systems in Saudi Arabia to remote communities where radiologists remain in critically short supply.
At its core, Rology offers a cloud-based teleradiology platform requiring no setup costs. It supports eight imaging modalities and 12 sub-specialities, delivering diagnostic reports in as little as 30 minutes. The company reports over 1.3 million completed scans and an impact on 1.2 million lives, powered by a distributed network of 200+ radiologists serving 300 hospitals.
The platform boasts FDA 510(k) clearance, 99.89% clinical accuracy, and up to 25% cost savings for hospitals — metrics that naturally drew investor attention. Returning lead investor Philips Foundation emphasised that its follow-on support reflects a belief in tech that “gives clinicians time back,” particularly in underserved regions. Sanofi, Johnson & Johnson Impact Ventures, and MIT Solve each echoed similar sentiment, pointing to the role of AI-powered diagnostics in closing critical healthcare gaps.
The new funding follows an active year of expansion in Saudi Arabia, where AI-driven healthtech competition is intensifying, and further scale across East Africa, especially Kenya. The team has launched eight AI tools for early diagnosis and workflow optimisation, leaning heavily on emerging agentic AI, LLMs, and foundation models. On the flip side, scaling such advanced tools in emerging markets can be tricky — but the company appears chuffed with its momentum.
Co-founders Moaaz Hossam and Mahmoud Eferawy said the round will help deepen Rology’s footprint in Africa and strengthen its position in the Kingdom. Given how much success in healthtech hinges not just on great tech but on strong institutional partnerships, the move feels timely. One detail that stands out: Rology’s push into multimodal intelligence across imaging types, which could prove a meaningful differentiator as AI diagnostics mature.
All in all, the round signals growing investor confidence, not only in Rology, but in a broader movement toward AI-driven, accessible healthcare across the MENA region.
